MedPath

Feasibility of a Self-management App for People With Knee Osteoarthritis (OA-AID Feasibility Study)

Not Applicable
Recruiting
Conditions
Knee Osteoarthristis
Registration Number
NCT06656845
Lead Sponsor
Diakonhjemmet Hospital
Brief Summary

In this feasibility trial, an 8-week digital intervention including remote monitoring in patients with knee osteoarthritis (OA) will be tested. The app will provide information on osteoarthritis and recommended treatment for people with knee OA.

Detailed Description

In this feasibility study various outcome measures will be assessed to determine whether the app (Genus) is viable, practical, and useful.

The study will test the feasibility of an 8-week digital intervention including remote monitoring prior to consultation in specialist healthcare. The app consist of information on osteoarthritis and recommended treatment for people with knee OA. A total of 20 patients referred to Diakonhjemmet Hospital due to knee OA will be recruited to the study. The study will include assessments of technical, operational, clinical, and trial aspects of feasibility. Data will be collected through digital questionnaires (through the app or Nettskjema), through interviews and from medical records. Primary outcome is the feasibility of the app after 8 weeks. Additionally, the feasibility of the study process until consultation in specialist healthcare will be assessed.

The aim of the app is to improve patients' health literacy and enhance the shared decision-making process between patient and healthcare provider at the consultation in specialist healthcare.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Men and women =>50 years of age
  • Referred to specialist healthcare for knee OA management
Exclusion Criteria
  • Received joint replacement or are under consideration for revision in the referred joint
  • Have uncontrolled serious comorbidities
  • Have cognitive dysfunction
  • Are seeking care for trauma conditions or psoriatic/rheumatoid arthritis
  • Unable to understand Norwegian
  • Do not have a smartphone

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Desirable feasibility levelThrough the 8 weeks intervention period

Acceptable overall feasibility of the app with ≥70% of the secondary endpoints indicating feasibility

Secondary Outcome Measures
NameTimeMethod
Patient-reported software usabilityAt 8 weeks

Considered feasible if the System Usability Scale score ≥68 on a 0-100 scale, 100= best score).

Patient-reported experiences and perceived benefitsAt 8 weeks

Experiences and perceived benefits collected in semi-structured interview

Integration of workflow for health professionalsAt baseline

Measured by registering time of time use: acceptable feasibility if \<30 minutes is spent on screening and enrolling (consent, baseline questionnaire, and downloading).

Patient satisfaction with the intervention at 8 weeksAt 8 weeks

Considered feasible if 70% with score ≥5 on a numeric rating scale (NRS) 0-10 on patient satisfaction with intervention.

Other patient reported outcomesThrough study completion (approx. 3 months after inclusion)

Available data on other patient reported outcomes at pre- and post-consultation questionnaires for ≥80% of the patients

Patient-reported satisfaction with the appAt 8 weeks

Measured by a numeric rating scale (NRS) 0-10, higher scores indicate better outcome. Acceptable feasibility 70% with score ≥5

Time use in the intervention periodThrough the 8 weeks intervention period

Acceptable feasibility if \<10 minutes are spent in max 1/3 of the patients

Primary clinical outcomeAt baseline and at study completion (approx. 3 months after inclusion)

Available data on total score in the Knee Osteoarthritis Knowledge Scale (KOAKS, scored on a scale from 11-55) at baseline and after intervention for ≥80% of patients.

Recruitment rateAt baseline

Acceptable recruitment rate is ≥50% of eligible patients

Patient dropoutAt 8 weeks

Number of patients that withdraw from the study. Acceptable withdrawal rate is ≤20% of included patients.

Trial logistics as assessed through interviewsAt study completion (approx. 3 months after inclusion)

Acceptable overall trial logistics as evaluated by the study group.

Patients' app useThrough study completion (approx. 3 months after inclusion)

Acceptable app use includes that ≥50% of the patients watch ≥80% of the videos (16 videos), ≥50% of the patients has exercised1 or more days, ≥50% have completed at least 1 quiz.

Potential risk and challenges as assessed through interviewsAt study completion (approx. 3 months after inclusion)

Identify potential risk and challenges that could hinder a successful clinical evaluation of the app in a large randomised, controlled trial: Acceptable overall potential risk and challenges as evaluated by the study group at end of study.

Software performance and functionalityThrough study completion (approx. 3 months after inclusion)

Acceptable number of errors (≤3 errors per patient) in the performance and functionality experienced by the patients and project group members

Trial Locations

Locations (1)

Diakonhjemmet hospital

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath